Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 60760-298

2 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 60760-298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (E628f96d 7191 4338 8d08 D79345348da4 01)

Mm1 (E628f96d 7191 4338 8d08 D79345348da4 01)
Chemical structure of Etodolac, showing its bicyclic core with an indole and a tetrahydrofuran ring, including the ethyl groups and carboxylic acid moiety visible in the molecular diagram.*
FDA Label Image

298-15 (Etodolac Extended Release 500mg 15ct 60760 298 15)

298-15 (Etodolac Extended Release 500mg 15ct 60760 298 15)
Label for Etodolac extended-release tablets, USP 500 mg, manufactured by Zydus Lifesciences Ltd., India, and packaged by St. Mary's Medical Park Pharmacy. The label includes dosage form, strength, quantity (15 tablets), storage instructions, dispensing guidance, and a medication guide contact for patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.